Neomycin-induced deafness in neonatal mice
Journal of Neuroscience Methods · 2023
DOI: 10.1016/j.jneumeth.2023.109852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroscience Methods, 2023. Verfasst von Raffaello M Cutri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA. Hauptthemen laut MEDLINE: Neomycin, Deafness. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: NIDCD NIH HHS, American Otological Society Inc.
Abstract (Originalsprache)
BACKGROUND: Hearing impairment is a rising public health issue, and current therapeutics fail to restore normal auditory sensation. Animal models are essential to a better understanding of the pathophysiology of deafness and developing therapeutics to restore hearing. NEW METHODS: Wild-type CBA/CaJ neonatal mice P2-5 were used in this study. Neomycin suspension (500 nl of 50 or 100 mg/ml) was micro-injected into the endolymphatic space. Cochlear morphology was examined 3 and 7 days after injection; hair cell (HC) loss, supporting cell morphology, and neurite denervation pattern were assessed with whole-mounts. At 2 and 4 weeks post-injection, the spiral ganglion neuron (SGN) density was analyzed with cryostat sections. Audiometric responses were measured with auditory brain response (ABR) at 4 weeks. RESULTS: Rapid and complete degeneration of the inner and outer HCs occurred as early as 3 days post-injection. Subsequently, time- and dose-dependent degeneration patterns were observed along the axis of the cochlear membranous labyrinth forming a flat epithelium. Likewise, the SGN histology demonstrated significant cell density reduction at 2 and 4 weeks. The ABR threshold measurements confirmed profound deafness at 4 weeks. COMPARISON WITH EXISTING METHODS: Compared to previously described local and systemic aminoglycoside injections, this method provides a reliable, robust, and rapid deafening model with a single infusion of neomycin in neonatal mice. This model also allows for investigating the effects of inner ear damage during auditory maturation. CONCLUSIONS: A single injection of neomycin into the endolymphatic space induces robust HC loss and denervation in neonatal mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA.
- Caruso Department of Otolaryngology-Head and Neck Surgery, University of Southern California, Los Angeles, CA 90033, USA.
- Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, CA 90089, USA.
- Caruso Department of Otolaryngology-Head and Neck Surgery, University of Southern California, Los Angeles, CA 90033, USA. Electronic address: Seiji.Shibata@med.usc.edu.
Förderung
- NIDCD NIH HHS
- American Otological Society Inc
Zitieren
APA
Cutri, R. M., Lin, J., Nguyen, N. V., Shakya, D., & Shibata, S. B. (2023). Neomycin-induced deafness in neonatal mice. Journal of Neuroscience Methods. https://doi.org/10.1016/j.jneumeth.2023.109852
Vancouver
Cutri RM, Lin J, Nguyen NV, Shakya D, Shibata SB. Neomycin-induced deafness in neonatal mice. Journal of Neuroscience Methods. 2023. doi:10.1016/j.jneumeth.2023.109852
BibTeX
@article{Cutri2023,
author = {Cutri, Raffaello M and Lin, Joshua and Nguyen, Nhi V and Shakya, Dejan and Shibata, Seiji B},
title = {Neomycin-induced deafness in neonatal mice},
journal = {Journal of Neuroscience Methods},
year = {2023},
doi = {10.1016/j.jneumeth.2023.109852}
}
EUVIMED